Company Quick10K Filing
Verso Quinnesec
10-Q 2021-03-31 Filed 2021-05-07
10-K 2020-12-31 Filed 2021-03-01
10-Q 2020-09-30 Filed 2020-11-12
10-Q 2020-06-30 Filed 2020-08-06
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-03-02
10-Q 2019-09-30 Filed 2019-11-12
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-08
10-K 2018-12-31 Filed 2019-03-01
10-Q 2018-09-30 Filed 2018-11-07
10-Q 2018-06-30 Filed 2018-08-08
10-Q 2018-03-31 Filed 2018-05-09
10-K 2017-12-31 Filed 2018-03-08
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-20
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-23
10-K 2015-12-31 Filed 2016-04-14
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-11
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-10
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-07
10-K 2013-12-31 Filed 2014-03-06
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-07
10-Q 2012-09-30 Filed 2012-11-14
10-Q 2012-06-30 Filed 2012-08-09
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-03-06
10-Q 2011-09-30 Filed 2011-11-07
10-Q 2011-06-30 Filed 2011-08-11
10-Q 2011-03-31 Filed 2011-05-09
10-K 2010-12-31 Filed 2011-03-03
10-Q 2010-09-30 Filed 2010-11-03
10-Q 2010-06-30 Filed 2010-08-11
10-Q 2010-03-31 Filed 2010-05-06
10-K 2009-12-31 Filed 2010-03-03
8-K 2020-11-09
8-K 2020-09-30
8-K 2020-08-05
8-K 2020-06-24
8-K 2020-06-09
8-K 2020-06-01
8-K 2020-05-12
8-K 2020-05-11
8-K 2020-04-13
8-K 2020-03-13
8-K 2020-03-10
8-K 2020-02-27
8-K 2020-02-18
8-K 2020-02-10
8-K 2020-01-31
8-K 2020-01-30
8-K 2020-01-23
8-K 2020-01-07
8-K 2019-12-23
8-K 2019-12-16
8-K 2019-12-10
8-K 2019-11-12
8-K 2019-11-11
8-K 2019-11-11
8-K 2019-10-03
8-K 2019-08-08
8-K 2019-06-17
8-K 2019-06-13
8-K 2019-05-08
8-K 2019-04-30
8-K 2019-04-05
8-K 2019-02-28
8-K 2019-02-06
8-K 2018-11-07
8-K 2018-09-24
8-K 2018-09-24
8-K 2018-08-16
8-K 2018-08-08
8-K 2018-07-13
8-K 2018-07-05
8-K 2018-05-09
8-K 2018-03-20
8-K 2018-03-08
8-K 2018-01-16

Verso Quinnesec Financials

VRS Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
11 Good Energy (ELVN)
1347 Capital Corp (TFSC)
Ameren Illinois Co (AILNP)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
1st United Bancorp (FUBC)
2-Track Global (TTG)
PALTALK, INC. (PALT)
Better World Acquisition Corp. (BWACW)
East Stone Acquisition Corp (ESSCW)
ENTERGY ARKANSAS, LLC (EAI)
21st Century Oncology Holdings (RTSX)
24Holdings (TWFH)
30DC (TDCH)
FUELCELL ENERGY INC (FCELB)
3D Total Solutions (DTLS)
3DX Industries (DDDX)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash565295561062131091147126141410440266910928898
Accounts Receivable9710184
Inventory196199167193141131160152138138155144129111536559540484485498399398373377398473459416
PP&E9519499359078191,4727627557421,5247227036881,2352,0532,0061,9312,7311,6941,6681,0741,0471,0471,0261,3151,007930940
Assets1,4861,4651,4441,3981,2161,2321,1551,1381,1181,1221,0861,0611,0439013,0512,9932,9172,7332,5832,5231,7621,7411,7091,7291,6991,7661,6591,635
Accounts Payable1271291111139492948083889681886320619217011388109157194216210215210210207
Long-Term Debt1,2581,2601,2621,3681,2221,2481,2831,2801,2951,2721,3691,3591,3701,3502,8232,8162,9332,9024434542,6002642031621080455024
Liabilities1,5441,5271,5751,5981,5371,5311,5071,5321,5211,5331,5871,6041,6211,6813,8573,8573,8913,9123,8503,8251,057995959891793822824768
Stockholders' Equity-247-221-352-394-403-411-501-543-578-780-806-864-974-1,179-1,267-1,302705746750838906944835867
Income Statement ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue399457450375373361333330375350299321350326806778782756690630635639644704695639602616
Cost of Revenue310288303665579
Gross Profit51632391116
R&D
SG&A22191819171819191818181818175546335347407-3625282524242923
Tax00-0-0-1000-100-1-2-20-100000010-1
Net Income-231-68-72-10328-38-43-10-20-91-43-36-184-122-60-111-129-88-33-21868636-11230
Cash Flow ($MM)2011-06-302011-09-302011-12-312012-03-312012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-06-302016-09-302016-12-312017-09-302018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating1362-7049-8319-339-9628-011-20419-9964-2586771-462362
Cash Investing-17-19-173833-19-13-14-9-12-72167-17-2349-18-14-24-5-18-21-36
Cash Financing-0-049-351-315-2298-1312-2045-2118-77296-42-6744-1-27